FDA Clears BresoDX1 for At-Home Sleep Apnea Testing
BresoDX1 is designed to record a patient’s physiological signals during sleep using a sensor and a pulse oximeter.
Diagnosis & Disease Information
FDA Approves Xenoview for Evaluating Lung Ventilation
The approval was based on data from 2 clinical trials that compared Xenoview MRI to xenon Xe 133 scintigraphy in adults with pulmonary disorders.
Target Recalls More Than 200,000 Weighted Blankets After 2 Children Suffocated
Four children have become trapped in the blankets, including a 4-year-old girl and a 6-year-old girl who both died
Actemra Approved for Treatment of Hospitalized COVID-19 Patients
Actemra (tocilizumab) is an interleukin-6 receptor antagonist.
In Face of Tripledemic, CVS and Walgreens Limit Purchases of Pediatric Pain Meds
Medication limits are meant to ‘ensure equitable access,’ according to a CVS statement
Nebulized Ensifentrine Significantly Improves Lung Function, COPD Symptoms
The ENHANCE-1 trial evaluated nebulized ensifentrine as monotherapy or as an add-on to a LAMA or a LABA in patients with moderate to severe COPD.
One in 7 Dual Users Continue Using Both Tobacco Products
However, early electronic cigarette quitters plus stable cigarette use was the most common trajectory in 41.6 percent of participants
Ready-to-Dilute Pemfexy Gains Additional NSCLC Indication
The ready-to-dilute formulation was developed to eliminate the reconstitution step with Alimta.
US Health Officials Urge Indoor Masking in Major Cities as ‘Tripledemic’ Rages
During the past few weeks, COVID-19, the flu, and respiratory syncytial virus have made millions of Americans ill
November 2022 Recap: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in November 2022 for investigational products in development.
